Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Cash-and-Equivalents" stands at 5.30 Billion United States Dollars as of 09/30/2025.
As of the end of Johnson & Johnson's third quarter, the item "Cash and Equivalents" stands at 5.30 Billion USD. This represents an increase of 14.25 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 9.28 percent compared to the value the year prior.
The 1 year change in percent is 9.28.
The 3 year change in percent is 249.47.
The 5 year change in percent is -72.06.
The 10 year change in percent is -61.16.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash and Equivalents | 905,699,262,464.00 |
![]() | AbbVie Inc - Cash and Equivalents | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash and Equivalents | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash and Equivalents | 280,205,508,085.11 |
![]() | Novartis AG - Cash and Equivalents | 255,096,620,580.91 |